SPRINT BIOSCIENCE AB revenue for the last year amounted to 54.00 M SEK, the most of which — 50.48 M SEK — came from its highest performing source at the moment, Small Molecules Drug, the year earlier bringing 83.00 k SEK. The greatest contribution to the revenue figure was made by United States — last year it brought SPRINT BIOSCIENCE AB 50.45 M SEK, and the year before that — 35.00 k SEK.